Medy-Tox Inc. (086900.KQ)
KRW 124900.0
(-2.42%)
KRW 124900.0
(-2.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 59.61 Billion KRW | 13.3% |
| 2022 | 52.61 Billion KRW | 59.6% |
| 2021 | 32.97 Billion KRW | -12.21% |
| 2020 | 37.55 Billion KRW | 28.03% |
| 2019 | 29.33 Billion KRW | 36.36% |
| 2018 | 21.51 Billion KRW | 85.29% |
| 2017 | 11.6 Billion KRW | 68.75% |
| 2016 | 6.87 Billion KRW | 17.75% |
| 2015 | 5.84 Billion KRW | 54.89% |
| 2014 | 3.77 Billion KRW | 121.4% |
| 2013 | 1.7 Billion KRW | 83.51% |
| 2012 | 928.35 Million KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 61.26 Billion KRW | 2.75% |
| 2024 Q2 | 62.45 Billion KRW | 1.94% |
| 2023 Q4 | 59.61 Billion KRW | -5.68% |
| 2023 FY | 59.61 Billion KRW | 13.3% |
| 2023 Q1 | 57.77 Billion KRW | 9.8% |
| 2023 Q2 | 61.94 Billion KRW | 7.22% |
| 2023 Q3 | 63.2 Billion KRW | 2.04% |
| 2022 FY | 52.61 Billion KRW | 59.6% |
| 2022 Q2 | 43.36 Billion KRW | 14.1% |
| 2022 Q1 | 38 Billion KRW | 15.26% |
| 2022 Q4 | 52.61 Billion KRW | 9.29% |
| 2022 Q3 | 48.14 Billion KRW | 11.04% |
| 2021 Q3 | 34.52 Billion KRW | -0.58% |
| 2021 Q4 | 32.97 Billion KRW | -4.49% |
| 2021 Q2 | 34.72 Billion KRW | -10.7% |
| 2021 Q1 | 38.88 Billion KRW | 3.53% |
| 2021 FY | 32.97 Billion KRW | -12.21% |
| 2020 Q4 | 37.55 Billion KRW | 20.99% |
| 2020 FY | 37.55 Billion KRW | 28.03% |
| 2020 Q3 | 31.04 Billion KRW | -9.59% |
| 2020 Q2 | 34.33 Billion KRW | -0.55% |
| 2020 Q1 | 34.52 Billion KRW | 17.7% |
| 2019 Q1 | 26.88 Billion KRW | 24.97% |
| 2019 Q2 | 32.34 Billion KRW | 20.33% |
| 2019 Q3 | 32.46 Billion KRW | 0.36% |
| 2019 Q4 | 29.33 Billion KRW | -9.65% |
| 2019 FY | 29.33 Billion KRW | 36.36% |
| 2018 FY | 21.51 Billion KRW | 85.29% |
| 2018 Q4 | 21.51 Billion KRW | 32.76% |
| 2018 Q3 | 16.2 Billion KRW | 22.59% |
| 2018 Q2 | 13.21 Billion KRW | 8.16% |
| 2018 Q1 | 12.21 Billion KRW | 5.26% |
| 2017 Q2 | 11 Billion KRW | 34.99% |
| 2017 Q1 | 8.15 Billion KRW | 18.53% |
| 2017 FY | 11.6 Billion KRW | 68.75% |
| 2017 Q4 | 11.6 Billion KRW | -13.22% |
| 2017 Q3 | 13.37 Billion KRW | 21.53% |
| 2016 Q3 | 5.31 Billion KRW | -18.5% |
| 2016 Q1 | 5.73 Billion KRW | -1.79% |
| 2016 FY | 6.87 Billion KRW | 17.75% |
| 2016 Q2 | 6.52 Billion KRW | 13.74% |
| 2016 Q4 | 6.87 Billion KRW | 29.33% |
| 2015 FY | 5.84 Billion KRW | 54.89% |
| 2015 Q4 | 5.84 Billion KRW | 25.59% |
| 2015 Q3 | 4.65 Billion KRW | -2.4% |
| 2015 Q2 | 4.76 Billion KRW | -1.44% |
| 2015 Q1 | 4.83 Billion KRW | 28.21% |
| 2014 Q1 | 1.94 Billion KRW | 14.43% |
| 2014 Q3 | 3.12 Billion KRW | 36.39% |
| 2014 Q4 | 3.77 Billion KRW | 20.59% |
| 2014 FY | 3.77 Billion KRW | 121.4% |
| 2014 Q2 | 2.29 Billion KRW | 17.64% |
| 2013 Q3 | 1.04 Billion KRW | 11.43% |
| 2013 Q1 | 1.01 Billion KRW | 9.46% |
| 2013 FY | 1.7 Billion KRW | 83.51% |
| 2013 Q2 | 941.33 Million KRW | -7.37% |
| 2013 Q4 | 1.7 Billion KRW | 62.42% |
| 2012 FY | 928.35 Million KRW | 0.0% |
| 2012 Q4 | 928.35 Million KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Co., Ltd. | 11.42 Billion KRW | -421.978% |
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -5796.317% |
| BINEX Co., Ltd. | 28.26 Billion KRW | -110.952% |
| Bioneer Corporation | 41.35 Billion KRW | -44.164% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | -3020.531% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | -310.679% |
| CrystalGenomics, Inc. | 1.55 Billion USD | -3734.463% |
| Helixmith Co., Ltd | 914.11 Million KRW | -6421.934% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | -74.748% |
| Peptron, Inc. | 172.18 Million KRW | -34523.863% |
| Amicogen, Inc. | 46.83 Billion KRW | -27.286% |
| Genexine, Inc. | 3.8 Billion KRW | -1466.035% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -1017.315% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -30188.363% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -5480.325% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | -18.684% |
| SillaJen, Inc. | 1.21 Billion KRW | -4816.436% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | -367.925% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -12627.741% |
| Genomictree Inc. | 496.53 Million KRW | -11906.877% |
| MedPacto, Inc. | 620.00 KRW | -9615792720.484% |
| D&D Pharmatech | 3.45 Billion KRW | -1627.946% |
| EASY BIO,Inc. | 25.93 Billion KRW | -129.843% |
| GI Innovation, Inc. | - KRW | -Infinity% |